Biomarkers for disease modification trials--the innovative medicines initiative and AddNeuroMed.
Lovestone
S
S
S. Lovestone, NIHR Biomedical Research Centre, South London and Maudsley NHS Trust and King's College London, London SE5 8AF, UK.
Francis
P
P
Strandgaard
K
K
D000544:Alzheimer Disease / Q000175:diagnosis* / Q000473:pathology; D015415:Biomarkers / Q000032:analysis*; D003955:Diagnostic Tests, Routine / Q000379:methods*; D018450:Disease Progression; D006801:Humans; D012720:Severity of Illness Index
D015415:Biomarkers